Drug Azlocillin Shows Promise at Completely Killing Off the Disease-causing Bacteria Borrelia burgdorferi

A new study out of Stanford university shows promise at completly killing off the disease-causing bacteria borrelia burgdorferi.  This disease-causing agent was typically prescribed common antibiotics​ to fight the infection.  For 20% of those patients the standard antibiotics​ did not work.

For those 20% of people antibiotics don’t work, and lingering symptoms of muscle pain, fatigue and cognitive impairment can continue for years.

The new drug azlocillin showed 100% efficacy in rats at the onset of the disease.

For more information refer to the Stanford University release titled Potential treatment for Lyme disease kills bacteria that may cause lingering symptoms, study finds